Bioanalytical Testing Services Market | Forecast 2028| Delvens

The global Bioanalytical Testing Services size is projected to reach a CAGR of 12.59% from 2022-2028.

Bioanalysis involves quantitative measurement of xenobiotics, like small molecule drugs and their metabolites and biological molecules. Bioanalytical testing services are used in the development and validation of robust bioanalytical methods in body fluids and tissue specimens. These tests are used to support pre-clinical and Phase I through Phase IV clinical trials.

The increased necessity for specific types of tests in R&D activities and the increasing trend of outsourcing laboratory testing services are some of the factors that have supported long-term expansion for Bioanalytical Testing Services.